当前位置: 首页 > 详情页

(3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one ameliorates retinal degeneration in Pde6b(rd10) mice

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Ophthalmology, Beijing Children’s Hospital, Capital Medical University, Beijing, P.R China [2]Department of Otorhinolaryngology, Shenzhen People’s Hospital, Shenzhen, P. R China
出处:
ISSN:

关键词: (3R)-5 6 7-trihydroxy-3-isopropyl-3-methylisochroman-1-one retinal degeneration oxidative stress rd10 mice

摘要:
As a severe photoreceptor-degenerative disease, retinitis pigmentosa (RP) is currently incurable and eventually leads to partial or complete blindness. (3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one (TIM) is a novel antioxidant isolated from the plant of Alpinia katsumadai Hayata, with protective effects on photoreceptor cells against lipoteichoic acid-induced damage through inhibiting oxidative stress. The present study was to further demonstrate whether TIM could ameliorate retinal degeneration of Pde6b(rd10) (rd10) mice, a mouse model of RP. rd10 mice were treated with TIM by intraperitoneal injection daily from postnatal Day 10 (P10) to P26. Retinal function was tested by electroretinography. Histology was evaluated by toluidine blue staining and TUNEL assay. Oxidative stress markers were measured by ELISA. Immunohistochemistry, real-time PCR, and western blotting were applied to explore the protective mechanism. Results showed TIM significantly improved the retinal function and decreased photoreceptor cell apoptosis in rd10 mice through reducing oxidative stress. For the first time, this study demonstrated the protective effects of TIM against retinal degeneration in rd10 mice, providing scientific rationale to use TIM treating the RP.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 眼科学 4 区 毒理学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 眼科学 4 区 毒理学
JCR分区:
出版当年[2016]版:
Q4 OPHTHALMOLOGY Q4 TOXICOLOGY
最新[2024]版:
Q3 OPHTHALMOLOGY Q4 TOXICOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Department of Ophthalmology, Beijing Children’s Hospital, Capital Medical University, Beijing, P.R China [*1]Department of Ophthalmology, Beijing Children’s Hospital, Capital Medical University, Beijing, P.R China
通讯作者:
通讯机构: [1]Department of Ophthalmology, Beijing Children’s Hospital, Capital Medical University, Beijing, P.R China [*1]Department of Ophthalmology, Beijing Children’s Hospital, Capital Medical University, Beijing, P.R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17688 今日访问量:0 总访问量:942 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院